Substituted urea neuropeptide Y Y5 Receptor antagonists

Details Substituted urea neuropeptide Y Y5 Receptor antagonists Substituted urea neuropeptide Y Y5 Receptor antagonists

2005-05-17

2005-05-17

Wang, Shengjun (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S277000, C514S359000, C514S210010, C514S212010, C546S195000, C564S037000, C540S001000, C540S484000, C548S400000

Reexamination Certificate

active

06894063

ABSTRACT:
A novel class of compounds such as antagonists of the neuropeptide Y Y5 receptor, methods of making such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention or amelioration of one or more diseases associated with the neuropeptide Y Y5 receptor are disclosed.

REFERENCES:
patent: 4405644 (1983-09-01), Kabbe et al.
patent: 4623662 (1986-11-01), De Vries
patent: 6355635 (2002-03-01), Elliott et al.
patent: 1 249 233 (2002-10-01), None
patent: WO 9719682 (1997-06-01), None
patent: WO 9835957 (1998-08-01), None
patent: WO 9964394 (1999-12-01), None
Stanley, et al. “Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behavior”Proc. Natl. Acad. Sci. 82:3940-3943(1985).
Billington, et al. “Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism”Am. J. Physiol. 260:R321-R327 (1991).
Wahlestedt, et al. “Neuropeptide Y-related peptides and their receptors—are the receptors potential therapeutic drug targets?”Annu. Rev. Pharmacol. Toxicol. 32:309-352(1993).
Gerald, et al., “A receptor subtype involved in neuropeptide-Y-induced food intake”Nature382:168-171 (1996).
Gehlert, D., “Minireview—Multiple Receptors for the Pancreatic Polypeptide (PP-Fold) Family: Physiological Implications”Proc. Soc. Exp. Biol. Med. 218:7-22(1998).
Michel, et al., “XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors”Pharmacol. Rev. 50(1):143-150(1998).
Hwa, et al., “Activation of the NPY Y5 receptor both feeding and energy expenditure”American J. Physiological277:(46):R1428-R1434(1999).
McNally JJ et al.: “N-Acylated alpha -(3-pyridylmethyl)-beta-aminotetralin antagonists of the human neuropeptide Y Y 5 receptor” Bioorganic & Medicinal Chemistry Letters, vol. 10, No. 15, Aug. 7, 2000, pp. 1641,-1643, XP004213213 ISSN: 0960-894X.

Affiliated with

Also associated with

Rating

Substituted urea neuropeptide Y Y5 Receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted urea neuropeptide Y Y5 Receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted urea neuropeptide Y Y5 Receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3460788